Comparison of Multivendor Single-Voxel MR Spectroscopy Data Acquired in Healthy Brain at 26 Sites

TitleComparison of Multivendor Single-Voxel MR Spectroscopy Data Acquired in Healthy Brain at 26 Sites
Publication TypeJournal Article
Year of Publication2020
AuthorsPovažan M, Mikkelsen M, Berrington A, Bhattacharyya PK, Brix MK, Buur PF, Cecil KM, Chan KL, Chen DYT, Craven AR, Cuypers K, Dacko M, Duncan NW, Dydak U, Edmondson DA, Ende G, Ersland L, Forbes MA, Gao F, Greenhouse I, Harris AD, He N, Heba S, Hoggard N, Hsu T-W, Jansen JFA, Kangarlu A, Lange T, R Lebel M, Li Y, Lin C-YE, Liou J-K, Lirng J-F, Liu F, Long JR, Ma R, Maes C, Moreno-Ortega M, Murray SO, Noah S, Noeske R, Noseworthy MD, Oeltzschner G, Porges EC, Prisciandaro JJ, Puts NAJ, Roberts TPL, Sack M, Sailasuta N, Saleh MG, Schallmo M-P, Simard N, Stoffers D, Swinnen SP, Tegenthoff M, Truong P, Wang G, Wilkinson ID, Wittsack H-J, Woods AJ, Xu H, Yan F, Zhang C, Zipunnikov V, Zöllner HJ, Edden RAE, Barker PB
JournalRadiology
Volume295
Issue1
Pagination171-180
Date Published2020 Apr
ISSN1527-1315
KeywordsAdult, Brain, Commerce, Female, Humans, Magnetic Resonance Spectroscopy, Male, Prospective Studies, Young Adult
Abstract

Background The hardware and software differences between MR vendors and individual sites influence the quantification of MR spectroscopy data. An analysis of a large data set may help to better understand sources of the total variance in quantified metabolite levels. Purpose To compare multisite quantitative brain MR spectroscopy data acquired in healthy participants at 26 sites by using the vendor-supplied single-voxel point-resolved spectroscopy (PRESS) sequence. Materials and Methods An MR spectroscopy protocol to acquire short-echo-time PRESS data from the midparietal region of the brain was disseminated to 26 research sites operating 3.0-T MR scanners from three different vendors. In this prospective study, healthy participants were scanned between July 2016 and December 2017. Data were analyzed by using software with simulated basis sets customized for each vendor implementation. The proportion of total variance attributed to vendor-, site-, and participant-related effects was estimated by using a linear mixed-effects model. P values were derived through parametric bootstrapping of the linear mixed-effects models (denoted Pboot). Results In total, 296 participants (mean age, 26 years ± 4.6; 155 women and 141 men) were scanned. Good-quality data were recorded from all sites, as evidenced by a consistent linewidth of N-acetylaspartate (range, 4.4-5.0 Hz), signal-to-noise ratio (range, 174-289), and low Cramér-Rao lower bounds (≤5%) for all of the major metabolites. Among the major metabolites, no vendor effects were found for levels of myo-inositol (Pboot > .90), N-acetylaspartate and N-acetylaspartylglutamate (Pboot = .13), or glutamate and glutamine (Pboot = .11). Among the smaller resonances, no vendor effects were found for ascorbate (Pboot = .08), aspartate (Pboot > .90), glutathione (Pboot > .90), or lactate (Pboot = .28). Conclusion Multisite multivendor single-voxel MR spectroscopy studies performed at 3.0 T can yield results that are coherent across vendors, provided that vendor differences in pulse sequence implementation are accounted for in data analysis. However, the site-related effects on variability were more profound and suggest the need for further standardization of spectroscopic protocols. © RSNA, 2020 Online supplemental material is available for this article.

DOI10.1148/radiol.2020191037
Alternate JournalRadiology
PubMed ID32043950
PubMed Central IDPMC7104702
Grant ListS10 OD012336 / OD / NIH HHS / United States
R01 NS096207 / NS / NINDS NIH HHS / United States
R01 MH095014 / MH / NIMH NIH HHS / United States
K01 AG050707 / AG / NIA NIH HHS / United States
F32 EY025121 / EY / NEI NIH HHS / United States
R01 EB016089 / EB / NIBIB NIH HHS / United States
F31 ES028081 / ES / NIEHS NIH HHS / United States
K01 AA025306 / AA / NIAAA NIH HHS / United States
R01 EB023963 / EB / NIBIB NIH HHS / United States
P50 HD103524 / HD / NICHD NIH HHS / United States
R01 AG054077 / AG / NIA NIH HHS / United States
K23 AA020842 / AA / NIAAA NIH HHS / United States
R00 MH107719 / MH / NIMH NIH HHS / United States
/ WT_ / Wellcome Trust / United Kingdom
S10 OD021726 / OD / NIH HHS / United States
T32 EY015387 / EY / NEI NIH HHS / United States
P41 EB015909 / EB / NIBIB NIH HHS / United States